An Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical Implications

<em>In vitro</em> survival measurements using two human head-and-neck cancer (HNC) cell lines were performed. The specially designed split-dose surviving fraction was obtained and fitted to the linear-quadratic formalism. The repair halftime (Tr), the potential doubling t...

Full description

Bibliographic Details
Main Authors: X. Allen Li, Steve P. Lee, Qiuhui Yang, X. Sharon Qi, Dian Wang
Format: Article
Language:English
Published: MDPI AG 2012-06-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/4/2/566
_version_ 1797764222683185152
author X. Allen Li
Steve P. Lee
Qiuhui Yang
X. Sharon Qi
Dian Wang
author_facet X. Allen Li
Steve P. Lee
Qiuhui Yang
X. Sharon Qi
Dian Wang
author_sort X. Allen Li
collection DOAJ
description <em>In vitro</em> survival measurements using two human head-and-neck cancer (HNC) cell lines were performed. The specially designed split-dose surviving fraction was obtained and fitted to the linear-quadratic formalism. The repair halftime (Tr), the potential doubling time (T<sub>d</sub>), a/β and radiosensitivity a, were estimated. Other radiobiological models: EUD, BED, TCP, <em>etc</em>., were used to examine the potential treatment effectiveness of different IMRT techniques. Our data indicated the repair halftime of ~17 min based on two HNC cell lines. The combined a/β, a and T<sub>d</sub> are a/β = 8.1 ± 4.1 Gy, a = 0.22 ± 0.08 Gy<sup>−1</sup>, T<sub>d</sub> = 4.0 ± 1.8 day, respectively. The prolonged IMRT dose delivery for entire HNC treatment course could possibly result in the loss of biological effectiveness, <em>i.e</em>., the target EUDs decreased by 11% with fraction dose delivery time varying from 5 to 30 min. We determined the sublethal damage repair halftime and other radiobiological parameters for HNC cells, and to evaluate treatment effectiveness of the prolonged dose delivery times associated with different IMRT techniques. The estimated repair halftime for HNC is relatively short and may be comparable to the step-and-shoot IMRT fraction dose delivery time. The effectiveness of IMRT treatment may be improved by reducing the fraction delivery time for HNC treatment.
first_indexed 2024-03-12T19:52:34Z
format Article
id doaj.art-fe189ee5775146588719c735c8275ac2
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T19:52:34Z
publishDate 2012-06-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-fe189ee5775146588719c735c8275ac22023-08-02T03:05:12ZengMDPI AGCancers2072-66942012-06-014256658010.3390/cancers4020566An Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical ImplicationsX. Allen LiSteve P. LeeQiuhui YangX. Sharon QiDian Wang<em>In vitro</em> survival measurements using two human head-and-neck cancer (HNC) cell lines were performed. The specially designed split-dose surviving fraction was obtained and fitted to the linear-quadratic formalism. The repair halftime (Tr), the potential doubling time (T<sub>d</sub>), a/β and radiosensitivity a, were estimated. Other radiobiological models: EUD, BED, TCP, <em>etc</em>., were used to examine the potential treatment effectiveness of different IMRT techniques. Our data indicated the repair halftime of ~17 min based on two HNC cell lines. The combined a/β, a and T<sub>d</sub> are a/β = 8.1 ± 4.1 Gy, a = 0.22 ± 0.08 Gy<sup>−1</sup>, T<sub>d</sub> = 4.0 ± 1.8 day, respectively. The prolonged IMRT dose delivery for entire HNC treatment course could possibly result in the loss of biological effectiveness, <em>i.e</em>., the target EUDs decreased by 11% with fraction dose delivery time varying from 5 to 30 min. We determined the sublethal damage repair halftime and other radiobiological parameters for HNC cells, and to evaluate treatment effectiveness of the prolonged dose delivery times associated with different IMRT techniques. The estimated repair halftime for HNC is relatively short and may be comparable to the step-and-shoot IMRT fraction dose delivery time. The effectiveness of IMRT treatment may be improved by reducing the fraction delivery time for HNC treatment.http://www.mdpi.com/2072-6694/4/2/566head-and-neck cancerlinear-quadratic modelsublethal damage repair halftimefraction dose delivery timeintensity modulated radiation therapy
spellingShingle X. Allen Li
Steve P. Lee
Qiuhui Yang
X. Sharon Qi
Dian Wang
An Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical Implications
Cancers
head-and-neck cancer
linear-quadratic model
sublethal damage repair halftime
fraction dose delivery time
intensity modulated radiation therapy
title An Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical Implications
title_full An Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical Implications
title_fullStr An Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical Implications
title_full_unstemmed An Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical Implications
title_short An Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical Implications
title_sort estimation of radiobiological parameters for head and neck cancer cells and the clinical implications
topic head-and-neck cancer
linear-quadratic model
sublethal damage repair halftime
fraction dose delivery time
intensity modulated radiation therapy
url http://www.mdpi.com/2072-6694/4/2/566
work_keys_str_mv AT xallenli anestimationofradiobiologicalparametersforheadandneckcancercellsandtheclinicalimplications
AT steveplee anestimationofradiobiologicalparametersforheadandneckcancercellsandtheclinicalimplications
AT qiuhuiyang anestimationofradiobiologicalparametersforheadandneckcancercellsandtheclinicalimplications
AT xsharonqi anestimationofradiobiologicalparametersforheadandneckcancercellsandtheclinicalimplications
AT dianwang anestimationofradiobiologicalparametersforheadandneckcancercellsandtheclinicalimplications
AT xallenli estimationofradiobiologicalparametersforheadandneckcancercellsandtheclinicalimplications
AT steveplee estimationofradiobiologicalparametersforheadandneckcancercellsandtheclinicalimplications
AT qiuhuiyang estimationofradiobiologicalparametersforheadandneckcancercellsandtheclinicalimplications
AT xsharonqi estimationofradiobiologicalparametersforheadandneckcancercellsandtheclinicalimplications
AT dianwang estimationofradiobiologicalparametersforheadandneckcancercellsandtheclinicalimplications